Evidence map›Paper›PMID 36075070›Full record

ArticleAmerican journal of respiratory and critical care medicine2022

Idiopathic Pulmonary Fibrosis Genetic Risk Factors, Function, and Mechanisms? The Concepts Are Starting to Gel.

Catherine A Bonham, Imre Noth

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Multi-omics insights into the mechanisms and prognosis of IPF.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2026
    Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Catherine A BonhamDivision of Pulmonary & Critical Care Medicine University of Virginia Charlottesville, Virginia.ORCID 0000-0001-9132-4083
Imre NothDivision of Pulmonary & Critical Care Medicine University of Virginia Charlottesville, Virginia.ORCID 0000-0001-9846-5030

Funding

Architectural structure and regulation of TOLLIP in IPFR01HL130796 · NHLBI · UNIVERSITY OF VIRGINIA · PI NOTH, IMRE · 2016 to 2019
$3.1M
Modeling to Design Treatments for Idiopathic Lung FibrosisR01HL155143 · NHLBI · UNIVERSITY OF VIRGINIA · PI BARKER, THOMAS HARRISON, PEIRCE-COTTLER, SHAYN · 2021 to 2024
$2.2M
1/2 Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases studyUG3HL145266 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MARTINEZ, FERNANDO J, NOTH, IMRE · 2019 to 2019
$977k
T cells in idiopathic pulmonary fibrosisK23HL143135 · NHLBI · UNIVERSITY OF VIRGINIA · PI BONHAM, CATHERINE ANN · 2018 to 2021
$662k
NHLBI NIH HHS K23 HL143135NHLBI NIH HHS R01 HL130796NHLBI NIH HHS R01 HL155143NHLBI NIH HHS UG3 HL145266
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Idiopathic Pulmonary FibrosisDNA MethylationGene ExpressionHumansMucin-5BRisk FactorsMUC5B protein, humanMucin-5B

Identifiers

PMID36075070
PMCPMC9746834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.